Point72 Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,300
Closed -$437K 3995
2025
Q4
$437K Buy
+4,300
New +$345K ﹤0.01% 3302
2025
Q1
Sell
-583,000
Closed -$32.8M 2183
2024
Q4
$32.8M Buy
+583,000
New +$36.3M 0.07% 322
2024
Q2
Sell
-170,000
Closed -$11.7M 2021
2024
Q1
$11.7M Buy
170,000
+130,000
+325% +$8.22M 0.03% 658
2023
Q4
$2.96M Buy
+40,000
New +$2.62M 0.01% 1086
2022
Q4
Sell
-25,000
Closed -$812K 1598
2022
Q3
$812K Buy
+25,000
New +$1.03M ﹤0.01% 1093

Other funds holding EXAS

Point72 Asset Management's EXAS Position: Q1 2026 in Review

Point72 Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 180,575 shares — an estimated $18.3M sold.

Point72 Asset Management first reported a position in EXAS in Q3 2014 and held it in 29 quarters. The position peaked at $136M in Q1 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Point72 Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 180,575 Exact Sciences shares in Q1 2026, an estimated $18.3M.
  • Point72 Asset Management first reported a position in Exact Sciences in Q3 2014 and held it in 29 quarters.
  • Point72 Asset Management's Exact Sciences position peaked at $136M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.